| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 ARHGAP26 TBC1D2 RGPD1 NRP1 SYDE2 ARHGAP29 PREX1 ARHGEF6 RGPD5 RANBP2 RGPD8 PREX2 | 6.62e-06 | 279 | 205 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | actin filament binding | ABL2 MYO5A MYO3A TLN2 FLNC TMEM201 SHROOM3 MYH7B FRG1 FSCN1 MARCKS | 2.39e-05 | 227 | 205 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.59e-05 | 20 | 205 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B2 BRIP1 MYO5A ATP8A2 COQ8B DNAH14 MYO3A CHD6 DNAH6 MYH7B CHD9 CHD7 MORC4 RFC4 DICER1 DDX53 SLFN11 DNAH11 | 6.70e-05 | 614 | 205 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | actin binding | ABL2 MYO5A MYO3A TLN2 MLPH FLNC TMEM201 SHROOM3 MYH7B FRG1 TNNC2 FSCN1 MARCKS MYBPC2 MYBPC3 | 1.35e-04 | 479 | 205 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | helicase activity | 2.33e-04 | 158 | 205 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | Pyrin domain binding | 3.13e-04 | 3 | 205 | 2 | GO:0032090 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 ARHGAP26 TBC1D2 RGPD1 NRP1 SYDE2 ARHGAP29 PREX1 ARHGEF6 RGPD5 CASP8AP2 RANBP2 HTR2A RGPD8 PREX2 DCP1B PSME3 | 4.53e-04 | 656 | 205 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 4.91e-04 | 36 | 205 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 6.21e-04 | 4 | 205 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 6.21e-04 | 4 | 205 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 6.21e-04 | 4 | 205 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 6.21e-04 | 4 | 205 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.77e-04 | 18 | 205 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 GBF1 ARHGAP26 TBC1D2 RGPD1 NRP1 SYDE2 ARHGAP29 PREX1 ARHGEF6 RGPD5 RANBP2 RGPD8 PREX2 | 7.86e-04 | 507 | 205 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 GBF1 ARHGAP26 TBC1D2 RGPD1 NRP1 SYDE2 ARHGAP29 PREX1 ARHGEF6 RGPD5 RANBP2 RGPD8 PREX2 | 7.86e-04 | 507 | 205 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.03e-03 | 5 | 205 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.03e-03 | 5 | 205 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.03e-03 | 5 | 205 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.03e-03 | 5 | 205 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.03e-03 | 5 | 205 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.03e-03 | 5 | 205 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.03e-03 | 5 | 205 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.38e-03 | 118 | 205 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.53e-03 | 6 | 205 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.72e-03 | 50 | 205 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 1.84e-03 | 24 | 205 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | BRIP1 ATP8A2 COQ8B CHD6 DNAH6 CHD9 CHD7 MORC4 RFC4 DDX53 SLFN11 DNAH11 | 2.09e-03 | 441 | 205 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.13e-03 | 7 | 205 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.13e-03 | 53 | 205 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.82e-03 | 8 | 205 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.82e-03 | 8 | 205 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.82e-03 | 8 | 205 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.89e-03 | 28 | 205 | 3 | GO:0051959 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.04e-06 | 9 | 200 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.12e-06 | 20 | 200 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.72e-06 | 10 | 200 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.73e-06 | 13 | 200 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 7.96e-06 | 14 | 200 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | primary neural tube formation | 2.26e-05 | 120 | 200 | 8 | GO:0014020 | |
| GeneOntologyBiologicalProcess | mitotic G2 DNA damage checkpoint signaling | 4.07e-05 | 40 | 200 | 5 | GO:0007095 | |
| GeneOntologyBiologicalProcess | neural tube formation | 4.99e-05 | 134 | 200 | 8 | GO:0001841 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 6.54e-05 | 71 | 200 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.05e-04 | 111 | 200 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | neural tube closure | 1.18e-04 | 113 | 200 | 7 | GO:0001843 | |
| GeneOntologyBiologicalProcess | tube closure | 1.24e-04 | 114 | 200 | 7 | GO:0060606 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.31e-04 | 115 | 200 | 7 | GO:0019319 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.63e-04 | 202 | 200 | 9 | GO:0021915 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 1.65e-04 | 159 | 200 | 8 | GO:0001838 | |
| GeneOntologyBiologicalProcess | melanocyte differentiation | 1.68e-04 | 29 | 200 | 4 | GO:0030318 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.80e-04 | 121 | 200 | 7 | GO:0046364 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 1.96e-04 | 163 | 200 | 8 | GO:0007093 | |
| GeneOntologyBiologicalProcess | heterochromatin organization | 2.39e-04 | 13 | 200 | 3 | GO:0070828 | |
| GeneOntologyBiologicalProcess | mitotic DNA damage checkpoint signaling | 2.59e-04 | 91 | 200 | 6 | GO:0044773 | |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 2.67e-04 | 59 | 200 | 5 | GO:0044818 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 2.78e-04 | 217 | 200 | 9 | GO:0000075 | |
| GeneOntologyBiologicalProcess | post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery | 2.79e-04 | 3 | 200 | 2 | GO:0000973 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 2.93e-04 | 173 | 200 | 8 | GO:0072175 | |
| GeneOntologyBiologicalProcess | negative regulation of mitotic cell cycle phase transition | 2.97e-04 | 219 | 200 | 9 | GO:1901991 | |
| GeneOntologyBiologicalProcess | mitotic DNA integrity checkpoint signaling | 3.27e-04 | 95 | 200 | 6 | GO:0044774 | |
| GeneOntologyBiologicalProcess | DNA damage checkpoint signaling | 3.69e-04 | 136 | 200 | 7 | GO:0000077 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.29e-10 | 18 | 205 | 7 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.09e-08 | 10 | 205 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 6.10e-07 | 8 | 205 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.19e-06 | 20 | 205 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore | 6.91e-06 | 101 | 205 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | annulate lamellae | 8.32e-06 | 14 | 205 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | supramolecular fiber | DCDC2C MYO5A TSC1 DNAH14 NRP1 MYL7 CEP170 MYO3A CCDC66 FBXO22 BAIAP2 CAMSAP1 PLK1 DNAH6 FLNC SHROOM3 HTR2A MYH7B FAM83H FRG1 TNNC2 TUBD1 FLACC1 MARCKS DNAH11 MYBPC2 MYBPC3 | 3.59e-05 | 1179 | 205 | 27 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | DCDC2C MYO5A TSC1 DNAH14 NRP1 MYL7 CEP170 MYO3A CCDC66 FBXO22 BAIAP2 CAMSAP1 PLK1 DNAH6 FLNC SHROOM3 HTR2A MYH7B FAM83H FRG1 TNNC2 TUBD1 FLACC1 MARCKS DNAH11 MYBPC2 MYBPC3 | 4.03e-05 | 1187 | 205 | 27 | GO:0099081 |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.72e-05 | 21 | 205 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 2.60e-04 | 90 | 205 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | myosin complex | 2.81e-04 | 59 | 205 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | growth cone | 7.27e-04 | 245 | 205 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 9.13e-04 | 253 | 205 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | DCDC2C MYO5A TSC1 DNAH14 NRP1 CEP170 MYO3A CCDC66 BAIAP2 CAMSAP1 PLK1 DNAH6 SHROOM3 HTR2A FAM83H TUBD1 FLACC1 MARCKS DNAH11 | 1.41e-03 | 899 | 205 | 19 | GO:0099513 |
| MousePheno | abnormal blastocyst formation | 1.02e-08 | 39 | 158 | 8 | MP:0012128 | |
| MousePheno | failure of blastocyst formation | 1.10e-06 | 31 | 158 | 6 | MP:0012129 | |
| MousePheno | decreased tumor latency | 1.96e-05 | 30 | 158 | 5 | MP:0010308 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.57e-05 | 16 | 158 | 4 | MP:0003701 | |
| MousePheno | increased lung carcinoma incidence | 2.78e-05 | 78 | 158 | 7 | MP:0008714 | |
| MousePheno | abnormal tumor latency | 3.70e-05 | 34 | 158 | 5 | MP:0010307 | |
| MousePheno | abnormal chromosome number | 5.25e-05 | 86 | 158 | 7 | MP:0004023 | |
| MousePheno | aneuploidy | 6.30e-05 | 61 | 158 | 6 | MP:0004024 | |
| MousePheno | increased carcinoma incidence | 8.07e-05 | 197 | 158 | 10 | MP:0002038 | |
| MousePheno | abnormal chromosome morphology | 9.07e-05 | 126 | 158 | 8 | MP:0003702 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | RGPD4 RGPD1 PLK1 KIT CASP8AP2 TICRR RANBP2 RGPD8 ZNF407 PCID2 | 1.04e-04 | 203 | 158 | 10 | MP:0011094 |
| MousePheno | abnormal morula morphology | 1.93e-04 | 26 | 158 | 4 | MP:0012058 | |
| MousePheno | increased respiratory system tumor incidence | 2.09e-04 | 107 | 158 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 2.09e-04 | 107 | 158 | 7 | MP:0008014 | |
| MousePheno | hypermyelination | 2.19e-04 | 11 | 158 | 3 | MP:0010050 | |
| MousePheno | abnormal body wall morphology | 3.16e-04 | 151 | 158 | 8 | MP:0003385 | |
| MousePheno | increased malignant tumor incidence | 3.63e-04 | 237 | 158 | 10 | MP:0002018 | |
| MousePheno | increased cystadenoma incidence | 3.78e-04 | 3 | 158 | 2 | MP:0013751 | |
| MousePheno | increased leiomyoma incidence | 3.78e-04 | 3 | 158 | 2 | MP:0003569 | |
| MousePheno | increased uterus leiomyoma incidence | 3.78e-04 | 3 | 158 | 2 | MP:0003570 | |
| MousePheno | absent lens vesicle | 3.78e-04 | 3 | 158 | 2 | MP:0009725 | |
| MousePheno | decreased litter size | BRIP1 NLRP7 AKR1C1 AKR1C2 FZD1 SAFB KIT GPD2 SELENOP NLRP2 PAPPA CLSPN DNAH11 | 3.80e-04 | 380 | 158 | 13 | MP:0001935 |
| MousePheno | abnormal tongue position | 3.90e-04 | 31 | 158 | 4 | MP:0031443 | |
| MousePheno | abnormal rod electrophysiology | 4.01e-04 | 119 | 158 | 7 | MP:0004021 | |
| MousePheno | embryonic lethality before implantation | RGPD4 RGPD1 PLK1 KIT CASP8AP2 TICRR RANBP2 RGPD8 ZNF407 PCID2 | 4.28e-04 | 242 | 158 | 10 | MP:0006204 |
| Domain | Ran_BP1 | 1.05e-07 | 12 | 202 | 5 | PF00638 | |
| Domain | RANBD1 | 1.05e-07 | 12 | 202 | 5 | PS50196 | |
| Domain | RanBD | 1.69e-07 | 13 | 202 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 1.69e-07 | 13 | 202 | 5 | IPR000156 | |
| Domain | PH_dom-like | RGPD4 ARHGAP26 TBC1D2 RGPD1 RTKN2 TLN2 PLD1 PREX1 ARHGEF6 RGPD5 RANBP2 RGPD8 PTPN21 PREX2 GTF2H1 DCP1B SKAP1 NUMB PLCH1 | 2.02e-07 | 426 | 202 | 19 | IPR011993 |
| Domain | - | RGPD4 ARHGAP26 TBC1D2 RGPD1 RTKN2 TLN2 PLD1 PREX1 ARHGEF6 RANBP2 RGPD8 PTPN21 PREX2 GTF2H1 DCP1B SKAP1 NUMB PLCH1 | 2.70e-07 | 391 | 202 | 18 | 2.30.29.30 |
| Domain | Grip | 4.13e-06 | 11 | 202 | 4 | SM00755 | |
| Domain | GRIP | 4.13e-06 | 11 | 202 | 4 | PF01465 | |
| Domain | GRIP_dom | 6.14e-06 | 12 | 202 | 4 | IPR000237 | |
| Domain | GRIP | 6.14e-06 | 12 | 202 | 4 | PS50913 | |
| Domain | BRK | 2.43e-05 | 6 | 202 | 3 | SM00592 | |
| Domain | BRK_domain | 2.43e-05 | 6 | 202 | 3 | IPR006576 | |
| Domain | BRK | 2.43e-05 | 6 | 202 | 3 | PF07533 | |
| Domain | Rab_bind | 4.23e-05 | 7 | 202 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 4.23e-05 | 7 | 202 | 3 | IPR032023 | |
| Domain | - | 1.41e-04 | 10 | 202 | 3 | 1.10.220.60 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.16e-04 | 14 | 202 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.16e-04 | 14 | 202 | 3 | IPR024743 | |
| Domain | MT | 4.16e-04 | 14 | 202 | 3 | PF12777 | |
| Domain | AAA_8 | 4.16e-04 | 14 | 202 | 3 | PF12780 | |
| Domain | DHC_fam | 5.15e-04 | 15 | 202 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.15e-04 | 15 | 202 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.15e-04 | 15 | 202 | 3 | IPR004273 | |
| Domain | Actin_cross-linking | 6.88e-04 | 4 | 202 | 2 | IPR008999 | |
| Domain | P-loop_NTPase | ATP6V1B2 BRIP1 NLRP7 MYO5A DNAH14 MYO3A RHOBTB1 CHD6 DNAH6 EFL1 MYH7B CHD9 CHD7 RFC4 NLRP2 DICER1 RASD1 DDX53 SLFN11 DNAH11 | 9.08e-04 | 848 | 202 | 20 | IPR027417 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.01e-06 | 55 | 138 | 7 | MM14917 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ABL2 ARHGAP26 SYDE2 ARHGAP29 PLD1 BAIAP2 PREX1 ARHGEF6 KTN1 PREX2 | 1.31e-05 | 184 | 138 | 10 | M41809 |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.42e-05 | 18 | 138 | 4 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.18e-05 | 40 | 138 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.72e-05 | 41 | 138 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 5.32e-05 | 42 | 138 | 5 | MM15039 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ABL2 ARHGAP26 SYDE2 ARHGAP29 BAIAP2 PREX1 ARHGEF6 KTN1 PREX2 | 5.54e-05 | 175 | 138 | 9 | MM15599 |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 5.55e-05 | 100 | 138 | 7 | MM14561 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.97e-05 | 43 | 138 | 5 | MM14609 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | RGPD4 BRIP1 RGPD1 PLK1 RANBP2 RGPD8 NUP98 RFC4 PSME3 CLSPN MAD2L1 | 7.20e-05 | 271 | 138 | 11 | MM15388 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 9.22e-05 | 47 | 138 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.13e-04 | 49 | 138 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.24e-04 | 50 | 138 | 5 | MM14610 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.27e-04 | 114 | 138 | 7 | MM15361 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.37e-04 | 51 | 138 | 5 | MM15151 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.41e-04 | 155 | 138 | 8 | M41808 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.50e-04 | 117 | 138 | 7 | MM15387 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.72e-04 | 84 | 138 | 6 | MM14929 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 ABL2 ARHGAP26 RGPD1 RHOBTB1 SYDE2 ARHGAP29 BAIAP2 PLK1 PREX1 ARHGEF6 RANBP2 RGPD8 KTN1 NUP98 PREX2 MAD2L1 | 2.01e-04 | 649 | 138 | 17 | MM15690 |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.53e-04 | 58 | 138 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.53e-04 | 58 | 138 | 5 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION | 2.56e-04 | 169 | 138 | 8 | MM14919 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.74e-04 | 129 | 138 | 7 | MM14894 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.17e-04 | 94 | 138 | 6 | MM15598 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.31e-04 | 65 | 138 | 5 | MM15147 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.70e-04 | 141 | 138 | 7 | MM15266 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.22e-04 | 193 | 138 | 8 | MM14890 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 7.36e-04 | 73 | 138 | 5 | MM14948 | |
| Pubmed | RGPD4 NLRP7 MYO5A ZNF658 RGPD1 TSC1 ZBTB41 FER1L6 LUZP1 KNOP1 FRA10AC1 RINT1 SAFB BBX STRN4 CDNF CHD6 DNAH6 MLPH PREX1 OBI1 MED13 RGPD5 FLNC RANBP2 RGPD8 MYH7B PCDHGA1 KTN1 NUP98 PTPN21 PRKACA ANKRD30A PLCH1 TUBD1 PCID2 PHTF1 MYBPC2 | 1.27e-14 | 1442 | 208 | 38 | 35575683 | |
| Pubmed | RGPD4 ZSCAN12 MYO5A RGPD1 MCC TSC1 TMEM132B LUZP1 CEP170 STRN4 SYT1 TLN2 BAIAP2 SPATS2 CAMSAP1 BEGAIN RANBP2 SHROOM3 OGT RGPD8 KTN1 DGKZ CHD7 PLPP3 PRKACA FSCN1 | 1.72e-10 | 963 | 208 | 26 | 28671696 | |
| Pubmed | ATP6V1B2 MYO5A GON4L CIC LUZP1 KNOP1 BBX METTL18 STRN4 CHD6 BAIAP2 SPATS2 MBD4 PREX1 CNOT3 MED13 RANBP2 SHROOM3 OGT KTN1 DGKZ CHD7 DICER1 GTF2H1 PHF3 FRG1 PRKACA NUMB MARCKS PCID2 | 6.95e-09 | 1497 | 208 | 30 | 31527615 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 9.03e-09 | 13 | 208 | 5 | 31427429 | |
| Pubmed | RGPD4 RGPD1 CIC LUZP1 CHD6 CAMSAP1 OBI1 CASP8AP2 RANBP2 OGT RGPD8 CHD7 MORC4 RESF1 ZMYM5 | 4.02e-08 | 418 | 208 | 15 | 34709266 | |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.29e-08 | 7 | 208 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.29e-08 | 7 | 208 | 4 | 11353387 | |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 30944974 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.29e-08 | 7 | 208 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.29e-08 | 7 | 208 | 4 | 17372272 | |
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 38657106 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 21205196 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 18949001 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 25187515 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 8603673 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 26632511 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 24403063 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 23818861 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 23536549 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 12191015 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 22821000 | ||
| Pubmed | 4.29e-08 | 7 | 208 | 4 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 8.54e-08 | 8 | 208 | 4 | 21670213 | |
| Pubmed | 8.54e-08 | 8 | 208 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 8.54e-08 | 8 | 208 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 8.54e-08 | 8 | 208 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 8.54e-08 | 8 | 208 | 4 | 28745977 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 TRPC4AP RGPD1 MCC ITPR1 CEP170 RTKN2 RINT1 STRN4 TLN2 PLK1 OBI1 CNOT3 CFAP97 BEGAIN RGPD5 RANBP2 OGT RGPD8 NUP98 XDH FAM83H FSCN1 MAD2L1 | 1.33e-07 | 1155 | 208 | 24 | 20360068 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.53e-07 | 9 | 208 | 4 | 18394993 | |
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 28100513 | ||
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 17887960 | ||
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 11553612 | ||
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 10601307 | ||
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 9733766 | ||
| Pubmed | 1.53e-07 | 9 | 208 | 4 | 28877029 | ||
| Pubmed | 2.54e-07 | 10 | 208 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.54e-07 | 10 | 208 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.54e-07 | 10 | 208 | 4 | 8857542 | |
| Pubmed | 2.54e-07 | 10 | 208 | 4 | 21859863 | ||
| Pubmed | 3.97e-07 | 11 | 208 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.97e-07 | 11 | 208 | 4 | 35771867 | |
| Pubmed | 3.97e-07 | 11 | 208 | 4 | 34110283 | ||
| Pubmed | BRIP1 MCC TSC1 CEP170 TMEM131L CHD6 BAIAP2 CAMSAP1 RGPD8 ICE2 KTN1 CHD7 PAIP1 DICER1 DCP1B PHF3 PLCH1 CLSPN | 5.13e-07 | 733 | 208 | 18 | 34672954 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 9480752 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | RGPD4 RNMT RGPD1 AKR1C1 AKR1C2 RANBP2 SHROOM3 RGPD8 NUP98 PREX2 | 1.20e-06 | 226 | 208 | 10 | 37839992 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GBF1 ABL2 CIC LUZP1 CEP170 SYDE2 BAIAP2 CAMSAP1 PLK1 OBI1 CFAP97 SHROOM3 PTPN21 FAM83H RESF1 DCP1B PHF3 NUMB PLCH1 | 1.21e-06 | 861 | 208 | 19 | 36931259 |
| Pubmed | 1.61e-06 | 15 | 208 | 4 | 14697343 | ||
| Pubmed | GBF1 TSC1 LUZP1 ITPR1 CEP170 RINT1 TMEM131L CAMSAP1 FLNC RANBP2 TMEM201 KTN1 NUP98 MARCKS PCID2 | 1.95e-06 | 568 | 208 | 15 | 37774976 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.12e-06 | 38 | 208 | 5 | 12791264 | |
| Pubmed | BRIP1 RNMT LUZP1 FANCF FBXO22 PLK1 MED13 OGT FAM83H GTF2H1 PHF3 PSME3 MAD2L1 | 3.93e-06 | 453 | 208 | 13 | 29656893 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 11859414 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ABL2 RGPD1 TSC1 LUZP1 RINT1 CCDC66 ARHGAP29 BAIAP2 CAMSAP1 PLK1 CFAP97 RANBP2 TMEM201 SHROOM3 PAIP1 FAM83H PPP2R3A PCID2 | 4.33e-06 | 853 | 208 | 18 | 28718761 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.32e-06 | 281 | 208 | 10 | 28706196 | |
| Pubmed | 8.36e-06 | 22 | 208 | 4 | 27717094 | ||
| Pubmed | ABL2 SREBF2 CIC RTKN2 CHD6 BAIAP2 OBI1 CASP8AP2 FLNC RANBP2 KTN1 NUP98 PRKACA | 8.36e-06 | 486 | 208 | 13 | 20936779 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 8.39e-06 | 168 | 208 | 8 | 30631154 | |
| Pubmed | GBF1 NKX2-3 AKR1C1 NRP1 FRA10AC1 RTKN2 MYO3A RHOBTB1 CASP7 TDRD1 ANKRD30A PHYHIPL | 8.63e-06 | 415 | 208 | 12 | 16385451 | |
| Pubmed | RNMT CNST ARHGAP26 SREBF2 ZBTB41 AKR1C1 AKR1C2 KNOP1 ITPR1 CD82 GLI1 TMEM131L SYT1 PLD1 ARHGEF6 TICRR OGT DGKZ CHD7 RESF1 | 9.17e-06 | 1084 | 208 | 20 | 11544199 | |
| Pubmed | 9.37e-06 | 225 | 208 | 9 | 12168954 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.20e-05 | 232 | 208 | 9 | 25515538 | |
| Pubmed | GBF1 SREBF2 TSC1 DMXL1 ITPR1 RINT1 TMEM131L PLD1 GPD2 TMEM201 SLC26A2 KTN1 MAD2L1 | 1.23e-05 | 504 | 208 | 13 | 34432599 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | GBF1 CEP170 SAFB TLN2 CAMSAP1 DNAH6 OBI1 UNC13B PHF3 ASXL3 C1orf94 | 1.27e-05 | 361 | 208 | 11 | 26167880 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 TSC1 CIC LUZP1 OBI1 CNOT3 CASP8AP2 OGT RGPD8 CHD7 MORC4 RESF1 SLFN11 CLSPN | 1.39e-05 | 588 | 208 | 14 | 38580884 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | LUZP1 CEP170 RINT1 SAFB FLNC RANBP2 ICE2 RFC4 RESF1 PHF3 PSME3 ZMYM5 | 1.69e-05 | 444 | 208 | 12 | 34795231 |
| Pubmed | ATP6V1B2 MYO5A ARHGAP26 NCAM2 TSC1 LUZP1 CEP170 SAFB STRN4 SYT1 TLN2 BAIAP2 DNAH6 GPD2 FLNC OGT KTN1 DGKZ PRKACA MAST1 PLCH1 FSCN1 DNAH11 | 1.76e-05 | 1431 | 208 | 23 | 37142655 | |
| Pubmed | ATP6V1B2 MYO5A TSC1 CIC LUZP1 ITPR1 RINT1 BAIAP2 PLK1 GPD2 EFL1 RANBP2 NUP98 PTPN21 PPP2R3A PRKACA NUMB SLFN11 MAD2L1 | 2.00e-05 | 1049 | 208 | 19 | 27880917 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ARHGAP26 AXIN2 BAIAP2 SPATS2 OBI1 CNOT3 MED13 RANBP2 ICE2 ZNF510 MAB21L2 GTF2H1 PHF3 PRKACA PSME3 | 2.15e-05 | 695 | 208 | 15 | 23602568 |
| Pubmed | 2.23e-05 | 251 | 208 | 9 | 27507650 | ||
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 2.27e-05 | 28 | 208 | 4 | 29879378 | |
| Pubmed | SECISBP2L GBF1 AKR1C1 AKR1C2 LUZP1 KNOP1 NRP1 CEP170 PDIA5 FLRT3 PLD1 BAIAP2 SPATS2 UNC13B KTN1 CHD7 RFC4 DICER1 PHF3 FRG1 NUMB MARCKS | 2.78e-05 | 1371 | 208 | 22 | 36244648 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 17513864 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 12386147 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27881734 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 8573067 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 28559319 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 22593191 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 15492289 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 32575385 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 33090377 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 18490758 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 27032039 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 20694145 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 15117313 | ||
| Pubmed | More than just a cargo adapter, melanophilin prolongs and slows processive runs of myosin Va. | 3.56e-05 | 2 | 208 | 2 | 23979131 | |
| Pubmed | Attenuated PLD1 association and signalling at the H452Y polymorphic form of the 5-HT(2A) receptor. | 3.56e-05 | 2 | 208 | 2 | 23314176 | |
| Pubmed | PKA mediates modality-specific modulation of the mechanically gated ion channel PIEZO2. | 3.56e-05 | 2 | 208 | 2 | 37146970 | |
| Pubmed | Activation of myosin Va function by melanophilin, a specific docking partner of myosin Va. | 3.56e-05 | 2 | 208 | 2 | 15760894 | |
| Pubmed | Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin. | 3.56e-05 | 2 | 208 | 2 | 29559472 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 18621368 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 16973906 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 19022247 | ||
| Pubmed | MARCKS and related chaperones bind to unconventional myosin V isoforms in airway epithelial cells. | 3.56e-05 | 2 | 208 | 2 | 20203291 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 21217827 | ||
| Pubmed | Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer. | 3.56e-05 | 2 | 208 | 2 | 16815967 | |
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 30454891 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 11929602 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 31162334 | ||
| Pubmed | 3.56e-05 | 2 | 208 | 2 | 11857508 | ||
| Interaction | RGPD4 interactions | 7.31e-08 | 22 | 208 | 6 | int:RGPD4 | |
| Interaction | YWHAZ interactions | BDP1 GBF1 ABL2 MYO5A MCC NCAM2 TSC1 CIC LUZP1 ITPR1 CEP170 MYO3A SYDE2 ARHGAP29 BAIAP2 CAMSAP1 ARHGEF6 TICRR SHROOM3 OGT PTPN21 FAM83H EXOC5 DCP1B PHF3 ASXL3 LOXL2 PRKACA LPIN2 MAST1 NUMB SLFN11 PLCH1 MARCKS | 6.91e-07 | 1319 | 208 | 34 | int:YWHAZ |
| Interaction | DYRK1A interactions | BDP1 GBF1 TBC1D2 TSC1 AKR1C2 CIC LUZP1 ADAMTS9 GLI1 CAMSAP1 PLK1 CNOT3 FLNC OGT ICE2 NUP98 FOXR2 GTF2H1 PRKACA LPIN2 | 1.24e-06 | 552 | 208 | 20 | int:DYRK1A |
| Interaction | RGPD2 interactions | 7.49e-06 | 27 | 208 | 5 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 1.09e-05 | 49 | 208 | 6 | int:RGPD1 | |
| Interaction | NPIPB6 interactions | 3.01e-05 | 18 | 208 | 4 | int:NPIPB6 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.43e-04 | 115 | 137 | 6 | 769 | |
| GeneFamily | EF-hand domain containing | 2.67e-04 | 219 | 137 | 8 | 863 | |
| GeneFamily | Dyneins, axonemal | 2.68e-04 | 17 | 137 | 3 | 536 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.93e-04 | 53 | 137 | 4 | 532 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 1.55e-03 | 8 | 137 | 2 | 658 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 RNMT MYO5A DMXL1 ITPR1 CEP170 FRA10AC1 RINT1 BBX CTHRC1 MBD4 KIT OBI1 CASP8AP2 ICE2 KTN1 THUMPD3 ZNF407 XRCC4 PAIP1 PPP2R3A PIEZO2 RESF1 PHF3 PUS7L | 1.02e-10 | 656 | 208 | 25 | M18979 |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | ARHGAP26 LUZP1 NRP1 CEP170 ADAMTS9 ARHGAP29 BAIAP2 CHD7 PARP14 PREX2 PIEZO2 PLPP3 TMEM44 FSCN1 MARCKS | 2.37e-08 | 304 | 208 | 15 | M39113 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL | MCC DIPK1B AKR1C1 AKR1C2 DNAH14 RNF150 FBXO22 CTHRC1 FLRT3 KIT FLNC SLC2A13 | 4.46e-06 | 294 | 208 | 12 | M45674 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | BDP1 ARHGAP26 LUZP1 NRP1 CEP170 ADAMTS9 ARHGAP29 CHD7 PREX2 PIEZO2 PLPP3 MARCKS | 4.62e-06 | 295 | 208 | 12 | M39121 |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN | ATP6V1B2 RNMT MYO5A ARHGAP26 ITPR1 PLD1 ARHGEF6 SELENOP CASP6 XRCC4 | 4.84e-06 | 200 | 208 | 10 | M8568 |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | ATP8A2 PTGR3 ADAMTS9 METTL18 CHD6 C6 MED13 CFAP97 ERICH3 PREX2 | 4.84e-06 | 200 | 208 | 10 | M7913 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | RGPD4 C2orf69 ATP6V1B2 GBF1 ARHGAP26 MCC ACOX3 ITPR1 FANCF CD82 ARHGAP29 TMEM131L CHD6 BAIAP2 SPATS2 PREX1 CHD7 DICER1 LOXL2 FRG1 AP5M1 FSCN1 MARCKS | 5.92e-06 | 1009 | 208 | 23 | M157 |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN | 2.74e-05 | 195 | 208 | 9 | M5857 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | RGPD4 RNMT RGPD1 GON4L LUZP1 CCDC66 BBX MBD4 RGPD5 RANBP2 OGT RGPD8 PHF3 ZMYM5 | 2.83e-05 | 474 | 208 | 14 | M40991 |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 3.34e-05 | 200 | 208 | 9 | M5192 | |
| Coexpression | DURAND_STROMA_S_UP | FZD1 RNF150 RTKN2 RHOBTB1 ARHGEF6 SELENOP MORC4 PLPP3 PAPPA SLFN11 MARCKS | 3.41e-05 | 304 | 208 | 11 | MM1083 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | RGPD4 ARHGAP26 RGPD1 LUZP1 FZD1 RANBP2 RGPD8 KTN1 CASP7 CHD7 PARP14 SLFN11 FSCN1 | 4.87e-05 | 435 | 208 | 13 | MM1221 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L GBF1 ITPR1 CEP170 BBX ARHGAP29 TMEM131L MED13 RANBP2 OGT NUP98 CHD9 XRCC4 PAIP1 DICER1 PPP2R3A PLPP3 PHF3 NUMB | 5.69e-05 | 856 | 208 | 19 | M4500 |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | NKX2-3 DIPK1B CEP170 RHOBTB1 CTHRC1 KIT SELENOP PAIP1 PREX2 TMEM44 PRDM16 | 5.89e-05 | 323 | 208 | 11 | M15107 |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | COQ8B MCC PTGR3 DMXL1 CFAP54 SPATS2 CAMSAP1 NUP98 CHD9 FAM83H GTF2H1 PIEZO2 PRDM16 | 5.99e-05 | 444 | 208 | 13 | M2505 |
| Coexpression | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN | 1.02e-04 | 31 | 208 | 4 | M4866 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000 | RNMT GON4L KNOP1 TMEM131L KIT TICRR TMEM201 SHROOM3 CHD7 DICER1 SKAP1 PSME3 PRDM16 PCID2 PUS7L | 3.84e-06 | 376 | 204 | 15 | gudmap_developingKidney_e11.5_metaneph mesench_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 LUZP1 SAFB BBX KIT CASP8AP2 RANBP2 KTN1 THUMPD3 CHD7 XRCC4 PREX2 EXOC5 PHF3 PAPPA CLSPN PHYHIPL MAD2L1 | 4.15e-06 | 532 | 204 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ZSCAN12 MYO5A RTKN2 CFAP54 CCDC66 TMEM131L CAMSAP1 KIT OBI1 UNC13B CASP8AP2 TICRR ICE2 CHD9 CHD7 TDRD1 ZNF605 PAPPA PLCH1 CLSPN PHYHIPL PRDM16 MAD2L1 ZMYM5 PHTF1 | 3.19e-05 | 1060 | 204 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | ATP6V1B2 ABL2 TSC1 DMXL1 NRP1 CEP170 ADAMTS9 FLRT3 PLK1 OBI1 CFAP97 CHD9 CHD7 PREX2 EXOC5 RESF1 ASXL3 LOXL2 PSME3 PRDM16 MARCKS | 4.08e-05 | 815 | 204 | 21 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 MYO5A LUZP1 SAFB CCDC66 CASP8AP2 RANBP2 ICE2 CHD7 DICER1 ZNF605 CLSPN | 5.03e-05 | 311 | 204 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | ZSCAN12 MYO5A ATP8A2 TSC1 KNOP1 RTKN2 CFAP54 CCDC66 FLRT3 CAMSAP1 MBD4 OBI1 UNC13B GPD2 CASP8AP2 TICRR EFL1 SHROOM3 KTN1 CHD9 CHD7 ZNF605 PHF3 LPIN2 PLCH1 CLSPN PHYHIPL PRDM16 PHTF1 | 5.15e-05 | 1370 | 204 | 29 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 ZSCAN12 MYO5A GON4L ZBTB41 LUZP1 SAFB CCDC66 STRN4 TMEM131L CAMSAP1 CASP8AP2 RANBP2 KTN1 CHD7 ZNF605 DCP1B PAPPA CLSPN PHYHIPL ZMYM5 | 5.39e-05 | 831 | 204 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 ZSCAN12 GON4L TSC1 ZBTB41 ACOX3 LUZP1 RINT1 CCDC66 STRN4 TMEM131L CAMSAP1 CFAP97 TICRR ICE2 CHD7 ZNF605 SLC2A13 CLSPN ZMYM5 | 6.71e-05 | 780 | 204 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 MYO5A LUZP1 KNOP1 SAFB CCDC66 KIT UNC13B CASP8AP2 RANBP2 ICE2 KTN1 CHD7 DICER1 ZNF605 DCP1B ZIC5 MAST1 PAPPA PLCH1 CLSPN PHYHIPL PHTF1 | 8.33e-05 | 989 | 204 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | BDP1 LUZP1 CCDC66 CASP8AP2 RANBP2 KTN1 CHD7 PAPPA CLSPN PHYHIPL | 8.67e-05 | 232 | 204 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_1000 | ABL2 NRP1 RBP7 ADAMTS9 ARHGAP29 CTHRC1 SPATS2 KIT PREX1 SELENOP CASP7 DGKZ CHD7 PREX2 EXOC5 PIEZO2 PLPP3 SLC2A13 FSCN1 MARCKS | 1.26e-04 | 817 | 204 | 20 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ZSCAN12 PTGR3 LUZP1 FRA10AC1 CCDC66 HPF1 TMEM131L FLRT3 KIT CASP8AP2 TICRR MYH7B ICE2 CHD9 CHD7 RFC4 TDRD1 PAIP1 GTF2H1 RESF1 ZNF41 ASXL3 CLSPN MARCKS MAD2L1 ZMYM5 | 1.54e-04 | 1241 | 204 | 26 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 ZSCAN12 MYO5A LUZP1 CCDC66 TMEM131L CAMSAP1 PLK1 OBI1 CFAP97 CASP8AP2 TICRR ICE2 KTN1 CHD9 CHD7 RFC4 DICER1 PREX2 EXOC5 PHF3 SKAP1 PAPPA CLSPN PHYHIPL PRDM16 MARCKS MAD2L1 ZMYM5 | 1.55e-04 | 1459 | 204 | 29 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.64e-04 | 204 | 204 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ZSCAN12 PTGR3 LUZP1 FRA10AC1 CCDC66 SH3RF2 HPF1 TMEM131L FLRT3 KIT CASP8AP2 TICRR MYH7B ICE2 CHD9 CHD7 RFC4 TDRD1 PAIP1 PREX2 GTF2H1 RESF1 ZNF41 ASXL3 SKAP1 CLSPN MARCKS MAD2L1 ZMYM5 | 1.72e-04 | 1468 | 204 | 29 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 ZSCAN12 MYO5A LUZP1 CCDC66 TMEM131L CAMSAP1 PLK1 OBI1 CFAP97 CASP8AP2 TICRR ICE2 KTN1 CHD9 RFC4 DICER1 EXOC5 PHF3 PAPPA CLSPN PHYHIPL PRDM16 MARCKS MAD2L1 ZMYM5 | 1.88e-04 | 1257 | 204 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_100 | 2.06e-04 | 88 | 204 | 6 | Facebase_ST1_e9.5_MaxilArch_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ZSCAN12 MYO5A ATP8A2 RTKN2 CFAP54 CCDC66 TMEM131L CAMSAP1 KIT OBI1 UNC13B CASP8AP2 TICRR ICE2 XDH CHD9 CHD7 TDRD1 ZNF605 SKAP1 PAPPA PLCH1 CLSPN PHYHIPL PRDM16 MAD2L1 ZMYM5 PHTF1 | 2.16e-04 | 1414 | 204 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 2.53e-04 | 129 | 204 | 7 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | kidney_adult_RenMedVasc_Tie2_k-means-cluster#4_top-relative-expression-ranked_200 | 2.72e-04 | 33 | 204 | 4 | gudmap_kidney_adult_RenMedVasc_Tie2_k4_200 | |
| CoexpressionAtlas | e9.5_MaxilArch_top-relative-expression-ranked_500 | RNMT CNOT3 CFAP97 SELENOP ATP23 CASP7 CHD7 MAB21L2 XRCC4 FSCN1 MAB21L1 PCID2 PUS7L | 3.43e-04 | 439 | 204 | 13 | Facebase_ST1_e9.5_MaxilArch_500 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CD82 ST8SIA6 KIT MLPH ARHGEF6 BEGAIN SLC26A2 TMEM44 SKAP1 MAB21L1 | 3.76e-08 | 200 | 208 | 10 | 96540be0e906bbc626049a41978be3dc051d2024 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CD82 ST8SIA6 KIT MLPH ARHGEF6 BEGAIN SLC26A2 TMEM44 SKAP1 MAB21L1 | 3.76e-08 | 200 | 208 | 10 | 41d7736427494cb30a2f23722ea2b86ff308cfd8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 168 | 208 | 9 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | DNAH14 RTKN2 SH3RF2 SYDE2 FLRT3 SHROOM3 PTPN21 PRDM16 SLC44A3 | 2.10e-07 | 183 | 208 | 9 | 942530449e9c6583705eeb8f6f12621daea57252 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | DNAH14 NRP1 CFAP54 ADAMTS9 ARHGAP29 PPP2R3A SLC2A13 PHYHIPL DNAH11 | 2.42e-07 | 186 | 208 | 9 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | TBC1D2 SREBF2 AKR1C1 CAPN8 ADAMTS9 SH3RF2 ARHGAP29 SHROOM3 CATSPERB | 2.64e-07 | 188 | 208 | 9 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 |
| ToppCell | Mast_cells|World / lung cells shred on cell class, cell subclass, sample id | CD82 ST8SIA6 KIT ARHGEF6 BEGAIN SLC26A2 TMEM44 SKAP1 MAB21L1 | 2.64e-07 | 188 | 208 | 9 | 229d24b87e945c4d543d11ac70761e45175ba0e5 |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-07 | 190 | 208 | 9 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-07 | 191 | 208 | 9 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-07 | 193 | 208 | 9 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-07 | 197 | 208 | 9 | fd76cc5e12c7e7943a48f739e4f0626ff7211f51 | |
| ToppCell | Biopsy_Other_PF-Immune-Mast_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.09e-07 | 198 | 208 | 9 | 9f015553598d4c6774b2f9759e8c0f0f93e51c67 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | SLC26A4 ANKRD36C AKR1C1 FER1L6 CAPN8 MLPH UNC13B SLC26A2 CATSPERB | 4.45e-07 | 200 | 208 | 9 | 292c63693eb7f435335a8cfba07aa35b72139393 |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.45e-07 | 200 | 208 | 9 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.45e-07 | 200 | 208 | 9 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 7.36e-07 | 156 | 208 | 8 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 1.35e-06 | 169 | 208 | 8 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 1.41e-06 | 170 | 208 | 8 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-06 | 176 | 208 | 8 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 178 | 208 | 8 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 178 | 208 | 8 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 181 | 208 | 8 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 181 | 208 | 8 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-06 | 181 | 208 | 8 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 182 | 208 | 8 | ab5761bf9af439231cd0f487b6467e372672a517 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 182 | 208 | 8 | 3b4dbf61ca0fe50efe05449815630e301cb76630 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.54e-06 | 184 | 208 | 8 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.54e-06 | 184 | 208 | 8 | bc394eaa441fcaffcc4ace062741bca1da229324 | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.54e-06 | 184 | 208 | 8 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | IPF-Myeloid-Mast|IPF / Disease state, Lineage and Cell class | 2.54e-06 | 184 | 208 | 8 | c3baf21f10b45cf91ac99997a59f353bcf3de8b7 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Mast_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-06 | 185 | 208 | 8 | a6e5328801c233a44153420e2cdae644b253f540 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.75e-06 | 186 | 208 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 186 | 208 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 2.86e-06 | 187 | 208 | 8 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 2.86e-06 | 187 | 208 | 8 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 187 | 208 | 8 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.98e-06 | 188 | 208 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP26 DNAH14 CFAP54 ADAMTS9 ARHGAP29 SLC2A13 PHYHIPL DNAH11 | 2.98e-06 | 188 | 208 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.10e-06 | 189 | 208 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.22e-06 | 190 | 208 | 8 | 7774dc0b4ae7d5920b516800f3b90cbf831f8d3d | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.22e-06 | 190 | 208 | 8 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 191 | 208 | 8 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-06 | 191 | 208 | 8 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-06 | 192 | 208 | 8 | f9777e0fdd86c2a514f05a42502888329a94b396 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-06 | 192 | 208 | 8 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-06 | 192 | 208 | 8 | 3a99c521c599a289ee2309d97be5ceb99f8aa220 | |
| ToppCell | facs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-06 | 192 | 208 | 8 | 562e15876088af9189744c9b2de5c4863d7f15fd | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 193 | 208 | 8 | e340064cd146deac03f2d0fd43e2e218bb6057c9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-06 | 193 | 208 | 8 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-06 | 193 | 208 | 8 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-06 | 193 | 208 | 8 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 193 | 208 | 8 | a211b386fd0fb9da9937361d29d90925a72c9715 | |
| ToppCell | facs-BAT-Fat-3m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-06 | 193 | 208 | 8 | 3086c33f4d6fab66966818737f95ae4d6b2615b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.76e-06 | 194 | 208 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-06 | 194 | 208 | 8 | aca009b9f1f320c0a65ea16df6595d7ede0b1fda | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-06 | 194 | 208 | 8 | 3b9ada901dfe7a5cc4861a883d3268c53b11e5b6 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.90e-06 | 195 | 208 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 3.90e-06 | 195 | 208 | 8 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.05e-06 | 196 | 208 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.37e-06 | 198 | 208 | 8 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.37e-06 | 198 | 208 | 8 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.37e-06 | 198 | 208 | 8 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 4.37e-06 | 198 | 208 | 8 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.37e-06 | 198 | 208 | 8 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 199 | 208 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-06 | 199 | 208 | 8 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 199 | 208 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-06 | 199 | 208 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 199 | 208 | 8 | 212e89d097753790061310373a1fafba773488b6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-06 | 199 | 208 | 8 | 14b676aa289c0578a37be32cec3ea285c79d97cc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-06 | 199 | 208 | 8 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-06 | 199 | 208 | 8 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell-Mast_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.70e-06 | 200 | 208 | 8 | 4090f2ab8529a530043f3917472f2d9ca7c9b1df | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 4.70e-06 | 200 | 208 | 8 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.70e-06 | 200 | 208 | 8 | cc78aa3e29f6c0a44c373dde7785c0e61978cf2d | |
| ToppCell | Lung_Parenchyma-Severe-Myeloid-Mast_cell-Mast_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.70e-06 | 200 | 208 | 8 | c3150b4bb621534b0094306b29534dbbe4ef7357 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.70e-06 | 200 | 208 | 8 | b706526b9c3485889a31253a1ffd017ad3f3fddc | |
| ToppCell | Sigmoid-Mast_cell-Mast|Sigmoid / Region, Cell class and subclass | 4.70e-06 | 200 | 208 | 8 | e7e49e192a86566ed96f1e54657dd2ebc9036d47 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 200 | 208 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Sigmoid-Mast_cell|Sigmoid / Region, Cell class and subclass | 4.70e-06 | 200 | 208 | 8 | 025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-Mast_cells|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.70e-06 | 200 | 208 | 8 | 56e2284df161e8ca32ce3e358369611345f4414e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.70e-06 | 200 | 208 | 8 | 4a57d6ba1531ce4e263daccd5de487977e6a1fdd | |
| ToppCell | Sigmoid-(7)_Mast_cell|Sigmoid / shred on region, Cell_type, and subtype | 4.70e-06 | 200 | 208 | 8 | bd8e0f027055bb34e99aa0e271ec3a0912f666bb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 200 | 208 | 8 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.57e-06 | 149 | 208 | 7 | cc911b454fe4e4b489885b9920baa7eb01a027ba | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.81e-06 | 153 | 208 | 7 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 8.87e-06 | 156 | 208 | 7 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 160 | 208 | 7 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 165 | 208 | 7 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 165 | 208 | 7 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-05 | 165 | 208 | 7 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 1.33e-05 | 166 | 208 | 7 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 168 | 208 | 7 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 170 | 208 | 7 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 170 | 208 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 170 | 208 | 7 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.55e-05 | 170 | 208 | 7 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.61e-05 | 171 | 208 | 7 | d934d68efc5739483c735dc702ccd30b07a6aa7e | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 172 | 208 | 7 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 1.67e-05 | 172 | 208 | 7 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A | ARHGAP26 TBC1D2 ITPR1 FZD1 CD82 KIT SPINK5 TDRD1 PLPP3 LOXL2 FSCN1 | 2.12e-06 | 198 | 207 | 11 | 4356_DN |
| Disease | congenital heart disease (implicated_via_orthology) | 4.78e-07 | 69 | 202 | 7 | DOID:1682 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.08e-05 | 7 | 202 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | GRISCELLI SYNDROME, TYPE 3 | 4.66e-05 | 2 | 202 | 2 | C1836573 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.89e-05 | 152 | 202 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Left ventricular noncompaction | 1.09e-04 | 14 | 202 | 3 | C1960469 | |
| Disease | Neoplasms, Hormone-Dependent | 1.39e-04 | 3 | 202 | 2 | C0027661 | |
| Disease | neuroimaging measurement | SECISBP2L RGPD1 LUZP1 NRP1 CD82 ST8SIA6 SYT1 TLN2 PLD1 SHROOM3 KTN1 CHD7 PTPN21 XRCC4 PAPPA PLCH1 TUBD1 PRDM16 DNAH11 | 1.50e-04 | 1069 | 202 | 19 | EFO_0004346 |
| Disease | coiled-coil domain-containing protein 134 measurement | 2.77e-04 | 4 | 202 | 2 | EFO_0802410 | |
| Disease | Male Germ Cell Tumor | 2.77e-04 | 4 | 202 | 2 | C3496549 | |
| Disease | Parkinson disease | 3.93e-04 | 321 | 202 | 9 | MONDO_0005180 | |
| Disease | Hermaphroditism | 4.60e-04 | 5 | 202 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 4.60e-04 | 5 | 202 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 4.60e-04 | 5 | 202 | 2 | C0033804 | |
| Disease | endometritis (biomarker_via_orthology) | 4.60e-04 | 5 | 202 | 2 | DOID:1002 (biomarker_via_orthology) | |
| Disease | Intersex Conditions | 4.60e-04 | 5 | 202 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 4.60e-04 | 5 | 202 | 2 | C2930619 | |
| Disease | IGF-1 measurement | SREBF2 BBX BAIAP2 TICRR SELENOP NUP98 DGKZ PPP2R3A RESF1 DCP1B MYBPC3 | 5.81e-04 | 488 | 202 | 11 | EFO_0004627 |
| Disease | Endometrioma | 8.74e-04 | 161 | 202 | 6 | C0269102 | |
| Disease | Endometriosis | 8.74e-04 | 161 | 202 | 6 | C0014175 | |
| Disease | Abnormality of the eye | 9.57e-04 | 7 | 202 | 2 | C4316870 | |
| Disease | Disorders of Sex Development | 9.57e-04 | 7 | 202 | 2 | C0036875 | |
| Disease | breast carcinoma (is_marker_for) | 1.10e-03 | 66 | 202 | 4 | DOID:3459 (is_marker_for) | |
| Disease | endometrial carcinoma | 1.10e-03 | 113 | 202 | 5 | EFO_1001512 | |
| Disease | Leukemia, Myelocytic, Acute | 1.27e-03 | 173 | 202 | 6 | C0023467 | |
| Disease | Acute Confusional Migraine | 1.63e-03 | 9 | 202 | 2 | C0521664 | |
| Disease | Status Migrainosus | 1.63e-03 | 9 | 202 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 1.63e-03 | 9 | 202 | 2 | C0270858 | |
| Disease | Sick Headaches | 1.63e-03 | 9 | 202 | 2 | C0700438 | |
| Disease | synaptotagmin-11 measurement | 1.63e-03 | 9 | 202 | 2 | EFO_0802108 | |
| Disease | Cervical Migraine Syndrome | 1.63e-03 | 9 | 202 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 1.63e-03 | 9 | 202 | 2 | C0018984 | |
| Disease | endometrial carcinoma, endometriosis | 2.46e-03 | 11 | 202 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | Alzheimer disease, polygenic risk score | SREBF2 DNAH14 NRP1 PCDHGA1 PAIP1 PPP2R3A RESF1 PHF3 SLC2A13 PLCH1 MARCKS | 2.49e-03 | 586 | 202 | 11 | EFO_0030082, MONDO_0004975 |
| Disease | chronic kidney disease (implicated_via_orthology) | 2.94e-03 | 12 | 202 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 2.94e-03 | 12 | 202 | 2 | EFO_1001304 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.44e-03 | 90 | 202 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | ventricular enlargement measurement | 3.46e-03 | 13 | 202 | 2 | EFO_0010570 | |
| Disease | Migraine Disorders | 3.46e-03 | 13 | 202 | 2 | C0149931 | |
| Disease | gallbladder cancer (is_implicated_in) | 3.46e-03 | 13 | 202 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | mean reticulocyte volume | BRIP1 CD82 SAFB TMEM131L TLN2 PLK1 PREX1 ZNF510 RESF1 LPIN2 MAST1 TUBD1 PRDM16 | 3.59e-03 | 799 | 202 | 13 | EFO_0010701 |
| Disease | obesity (implicated_via_orthology) | 3.75e-03 | 215 | 202 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Fanconi anemia | 4.02e-03 | 14 | 202 | 2 | cv:C0015625 | |
| Disease | 3-hydroxyphenylacetic acid measurement | 4.02e-03 | 14 | 202 | 2 | EFO_0010448 | |
| Disease | myopathy (implicated_via_orthology) | 4.36e-03 | 48 | 202 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | overall survival, pancreatic carcinoma | 4.62e-03 | 49 | 202 | 3 | EFO_0000638, EFO_0002618 | |
| Disease | cognitive function measurement | GBF1 NCAM2 CAPN8 MYO3A CCDC66 BBX SYT1 BAIAP2 CLNK PREX1 GPD2 EFL1 ATP23 CHD7 MAST1 DDX53 SLC44A3 MYBPC2 MYBPC3 | 4.67e-03 | 1434 | 202 | 19 | EFO_0008354 |
| Disease | brain measurement, neuroimaging measurement | RGPD1 LUZP1 NRP1 ADAMTS9 SYT1 KTN1 PAPPA CATSPERB PRDM16 DNAH11 | 4.83e-03 | 550 | 202 | 10 | EFO_0004346, EFO_0004464 |
| Disease | response to methotrexate | 5.25e-03 | 16 | 202 | 2 | GO_0031427 | |
| Disease | myeloid white cell count | RNMT ARHGAP26 MCC CIC BBX SYT1 TLN2 KIT PREX1 SELENOP CHD7 PREX2 PLPP3 SKAP1 | 5.37e-03 | 937 | 202 | 14 | EFO_0007988 |
| Disease | interleukin 1 receptor antagonist measurement | 5.76e-03 | 53 | 202 | 3 | EFO_0004754 | |
| Disease | Vitiligo | 5.93e-03 | 17 | 202 | 2 | C0042900 | |
| Disease | food allergy measurement | 5.93e-03 | 17 | 202 | 2 | EFO_0007016 | |
| Disease | platelet crit | PTGR3 RNF150 BBX ARHGAP29 TMEM131L PDIA5 KIT PREX1 ZNF407 PLPP3 SKAP1 NUMB PRDM16 FLACC1 | 6.15e-03 | 952 | 202 | 14 | EFO_0007985 |
| Disease | body weight | SECISBP2L C2orf69 RGPD1 GON4L DNAH14 AXIN2 ITPR1 TLN2 BAIAP2 KIT UNC13B CHD7 PHF3 ASXL3 SKAP1 RASD1 PAPPA | 6.21e-03 | 1261 | 202 | 17 | EFO_0004338 |
| Disease | leukemia | 6.38e-03 | 55 | 202 | 3 | C0023418 | |
| Disease | factor VII measurement | 6.38e-03 | 55 | 202 | 3 | EFO_0004619 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 6.64e-03 | 18 | 202 | 2 | C0342384 | |
| Disease | Bone marrow hypocellularity | 6.64e-03 | 18 | 202 | 2 | C1855710 | |
| Disease | fibrinogen measurement | 6.78e-03 | 109 | 202 | 4 | EFO_0004623 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKCSENGTVDVADKL | 1101 | Q9BXT4 | |
| GQTDKCREETFKQES | 771 | Q5SW79 | |
| GSLAKEAFLCKEDVE | 1016 | Q5RHP9 | |
| EVSARKDCVGSKESA | 1741 | A6H8Y1 | |
| QNDDVCDSADGRKKT | 2776 | Q96N23 | |
| FKQTNEDELSVCKGD | 171 | Q15052 | |
| FEEGKKCETNSVFDK | 21 | Q9P2B7 | |
| NRKRCLEDSEDFGVK | 211 | Q9NXR5 | |
| DCLLGSAKLDEEFEK | 681 | Q8WY36 | |
| KDDTEKRFACSNKGF | 26 | Q9H7T0 | |
| FKGEKGECLRESFEE | 86 | Q96CG8 | |
| QGEKVRTCEKSDESA | 231 | Q8N8R5 | |
| ELISFCLDTKGKENR | 66 | Q49AH0 | |
| EKRSGSSDFEARNKC | 536 | O15254 | |
| LEDAKETCFTRDRKG | 636 | P42684 | |
| DASARDLAFCDGVEK | 201 | Q9BUH8 | |
| SGDKQCTDTFGKEVE | 491 | Q99965 | |
| QDGCSEAFEKRTSQK | 931 | Q7Z2Z2 | |
| KDLNAELFDCKDSGI | 346 | Q9NZU0 | |
| QDDSKVFKEGSCLLA | 216 | P28223 | |
| CLEKATSGKFEQSAE | 341 | Q9BXX3 | |
| SIKSFEAQEKTLCGD | 3396 | Q96DT5 | |
| KKASDEFACGAVFEE | 806 | Q9Y2T1 | |
| DGEFCLRVFSEKKAQ | 496 | A6NHC0 | |
| LCAAEVKSSKGTEDR | 211 | Q6P1W5 | |
| LRNKCSKSVDTGETD | 586 | Q9UPY3 | |
| KCGIEETLDSKARSD | 116 | Q5VUD6 | |
| VCDSKSFGRDSDEGK | 1151 | Q9UKL3 | |
| DCGDAVSKTEDFLVK | 946 | Q5T5Y3 | |
| ECEAEASSVKNELKG | 2206 | Q9P2D1 | |
| EFFATAGKDDCLLKV | 181 | Q9Y485 | |
| GNEDEDKKACQFKRS | 211 | Q9UN42 | |
| SFGICKEKRARIEDD | 971 | Q9C0F0 | |
| CKGADNVIFERLSKD | 591 | Q9NTI2 | |
| CEVKGEEDNSLSVRK | 176 | P27701 | |
| EEDNSLSVRKGFCEA | 181 | P27701 | |
| NCTTENSEDDKKRGR | 276 | O75175 | |
| AELLCKNDVTDGRAK | 101 | P49792 | |
| TGEEDEEEFFCNRAK | 1186 | P49792 | |
| ASAGSQAKDKERCVI | 266 | Q9Y272 | |
| AELLCKNDVTDGRAK | 101 | Q99666 | |
| AELLCKNDVTDGRAK | 101 | O14715 | |
| SKFCEADVSSDLRKE | 26 | Q9NWY4 | |
| DATENECREFSATKK | 906 | Q9UPP5 | |
| KIRDCAANTFIEDSG | 406 | Q7Z5J8 | |
| SAEKLDAACGIDKTE | 471 | Q5JPF3 | |
| AKKAVDEVFESCFND | 201 | Q9Y6H3 | |
| ERKLEDAGSCEGQEK | 156 | Q5HY64 | |
| GNFILRKCNEVKDDD | 371 | Q8NEZ5 | |
| AKITNEKGECIVSDF | 751 | P52948 | |
| IRVSINEKCGKEFSE | 336 | P17612 | |
| LTALETCKAQDGDFE | 326 | Q9NPI8 | |
| KDVLTGQEFDVRAKC | 271 | P43304 | |
| QFDIECDKTAKDDSA | 101 | Q13257 | |
| GEEDKKINESCSAVF | 271 | Q96Q35 | |
| CSVDQEGKSVLSEKF | 186 | P10721 | |
| TKICDFGLARDIKND | 806 | P10721 | |
| ICGLERDKFDNKTVT | 2621 | Q14643 | |
| APTELNCDDFKKGER | 91 | Q9NQ38 | |
| NCDDFKKGERDGDFI | 96 | Q9NQ38 | |
| TGNEKSIIDCKFNAE | 396 | Q9Y4K0 | |
| LGFEVKCFNDLKAEE | 81 | P55212 | |
| LSDSEARCGDIQKTK | 581 | Q5VYM1 | |
| FSDDERCGESSKRKK | 11 | Q70Z53 | |
| EGVEAANAKCSSLEK | 1451 | A7E2Y1 | |
| EFKEAFSCIDQNRDG | 36 | Q01449 | |
| LCKGKFDFLERLSDD | 86 | Q8NEA4 | |
| KAEIAFEDRKDGSCG | 2356 | Q14315 | |
| DISRSENEKKSECFS | 446 | Q5W0B1 | |
| LAAVKEDAAATKDRC | 341 | Q86UP2 | |
| EARDVGDTCSVGKKD | 176 | Q1ED39 | |
| SESQKGEERDRKCSA | 36 | O95568 | |
| EGCSKAFSNASDRAK | 336 | P08151 | |
| ANEKRAKELEATFGC | 561 | Q9NX02 | |
| KDFVESRDSCSRINK | 66 | Q9H0R1 | |
| DGVCEEFEQKTSIKD | 996 | Q13219 | |
| VECKSSRGSLSQEKE | 606 | Q06190 | |
| EKDAREFLDKQVCGT | 536 | Q9Y2H9 | |
| CRTEYEVKDQAAKGD | 246 | Q9H074 | |
| GKEVATRATNDERCK | 871 | Q16825 | |
| CRGKVSEGLDFSDDN | 761 | Q9BX63 | |
| AFRNDKCGDTIKIES | 21 | O14786 | |
| EKKTESATFRVCGEN | 1421 | Q460N5 | |
| VCASDTRAGIEDSKK | 151 | Q5JVF3 | |
| EESERKQNALGKCDA | 951 | Q52LW3 | |
| LFGKQDKATCQETVE | 231 | Q8IZD4 | |
| FIRCNEAGDIEAKSK | 156 | Q14331 | |
| EDRVVCNDKFAEDGA | 376 | Q9UP38 | |
| SFVKEQLEECRKSDA | 286 | O00471 | |
| SRLDGKTEKVDDGFC | 966 | Q9P2N4 | |
| DRVLEVSFCEDKDTG | 776 | Q3L8U1 | |
| SCDTEFTKEDEQRLK | 556 | P23508 | |
| DKSVGDRESSIKQFC | 791 | Q9C0G6 | |
| IACRDTEFSDKEKGN | 46 | Q9NZH7 | |
| DGCKSEADKFTVREA | 81 | O95976 | |
| DQGFESCEKVSNSDK | 486 | Q659A1 | |
| TKVGKDELFALEQSC | 246 | Q16658 | |
| EEADCKNKFRCDSGR | 136 | P13671 | |
| VFSEKKDDSRAAQDG | 1366 | Q8TD26 | |
| DFEGNKDKEDARLCE | 336 | A8MYV0 | |
| CGLFEEQQAFEKSRK | 1701 | Q3T8J9 | |
| GERECDRSSLEAKKA | 251 | A2RUB6 | |
| KAAADGDRDCVLQKS | 406 | Q96D53 | |
| VRNGTDKDAEALFKC | 86 | P55210 | |
| DKDAEALFKCFRSLG | 91 | P55210 | |
| QARGSFDISCDKDNK | 116 | P49913 | |
| KREFKCDTSDSLSEA | 1326 | Q0VDD8 | |
| EKKAEEAGASAAACE | 266 | P29966 | |
| EKLEEAFSRSKNDCT | 121 | Q86V48 | |
| AEVKAEGFNLLSKEC | 201 | Q9Y586 | |
| DSKRESVCNKADAES | 261 | O95243 | |
| EFEDDLVKESSSCGK | 61 | O43148 | |
| KDEGSNCSEDKVVES | 116 | Q6PJQ5 | |
| CSDLEEAVDSGADKK | 661 | Q92538 | |
| CFAVDLETNDGSSEK | 596 | Q8N4M1 | |
| FNITCDDLKSGEKRL | 201 | Q86TM3 | |
| DAKAGEKFVEEACRL | 41 | Q6ZQY3 | |
| GEELIEAAKRNDFCK | 791 | Q13574 | |
| DKDKCSAIFRSDSLG | 1086 | Q6ZRV2 | |
| ELKCADIDRDGKVNF | 91 | Q8N7B9 | |
| KFLEELKRCNSGSDS | 221 | Q8N7B9 | |
| KSLETAGDCKAAEES | 126 | Q8TAU0 | |
| LCEASRDEQAFLGKD | 91 | Q6PJW8 | |
| KSQGKDDDSFDRKSV | 556 | Q9BV36 | |
| DAFKDDRKIACAAVD | 441 | Q14554 | |
| NALKEKGSVAEAEDC | 301 | O15294 | |
| TSGDFEKDDDACKTE | 1001 | P0DJD0 | |
| ADTLISQESCEKKGF | 776 | Q9Y5H4 | |
| RNSSNDATFEIKKCD | 26 | P29803 | |
| KREKECGVTATFDAS | 171 | P49757 | |
| KGDKETESDFDNCAV | 266 | Q9ULK6 | |
| GRCENETKFKTEDIF | 481 | Q96QE2 | |
| EGFLDIDTKFSENRC | 486 | Q8ND04 | |
| KACDLAKFENASEET | 1726 | Q2WGJ9 | |
| KDNKFLTCTEEDGVL | 306 | Q96FC7 | |
| NQTGRCDVKFESKER | 81 | Q8IZC4 | |
| CGSAAVKKELREAFE | 856 | Q5VT97 | |
| AEKEEQEKLGDICFS | 266 | P21579 | |
| DAKKTSCEFTGDILR | 106 | P21281 | |
| CQSGSFDKLEAVVKD | 281 | P35249 | |
| AELLCKNDVTDGRAK | 101 | Q7Z3J3 | |
| CTEGVTKRLAEKNDF | 176 | Q8TEL6 | |
| KTSENTAEFKERELC | 1091 | A2VDJ0 | |
| EDDEEKKGRGCSLQY | 551 | Q14DG7 | |
| DDGKEEASEQIFATC | 276 | Q7Z3H4 | |
| AEVKAEGFNLLSKEC | 201 | Q13394 | |
| CRGDDSKVQEARKSF | 181 | O14495 | |
| SCADDKVVFNKIGDA | 786 | Q13393 | |
| SKCEEKADVLSSFLD | 116 | Q9H0K6 | |
| EQELVAGQFSSKCDK | 1271 | Q9HCM1 | |
| KISEDLGSEKFCVDA | 146 | Q9HAZ2 | |
| EEVKNKSCLTFTDDG | 76 | Q8TE76 | |
| KTDSIEKRFCFDVEA | 326 | Q9UNA1 | |
| KVCFKVAEEDQEDSG | 1146 | Q8TCU6 | |
| NKSLCGTEIDKSDFV | 196 | P61647 | |
| SSGCEGKRNEDKEAV | 1726 | Q8TF72 | |
| DDKSREVLGCAKENV | 251 | Q7Z7L1 | |
| DGLEASENEKEVSCK | 886 | Q93073 | |
| ANEKRAKELEATFGC | 526 | Q8WX94 | |
| GSEGACEKEKQSRDF | 306 | O94844 | |
| RNTDCGKEAEKRFEA | 1151 | Q9UHV7 | |
| GDERKKACLSALSEV | 221 | A4QPH2 | |
| KDEDFCKRVSLATVD | 181 | P49908 | |
| KEDGRKFDFDACNEV | 351 | Q15424 | |
| EQRSKGDALDKCQAE | 126 | Q9UQB8 | |
| KDENGKILFDTVDLC | 131 | Q04828 | |
| KDENGKILFDTVDLC | 131 | P52895 | |
| ENKDGSFLVRDCSTK | 326 | Q7Z7G1 | |
| DGFGTTDIDLKCKER | 456 | Q96RK0 | |
| TGSDESCRKDLVKNE | 391 | Q9HAW4 | |
| KRRLDECEEAFQGTK | 86 | P61289 | |
| NIIRKEVEKCDSFSG | 121 | Q9UJT1 | |
| CDVETLKKSIDSFGQ | 356 | Q86XZ4 | |
| NTGSKDLFAECAKID | 236 | P32780 | |
| KARELFRNKSESQCD | 1091 | Q92574 | |
| CDLREDSEVSKSKEG | 1791 | Q7Z2Z1 | |
| CRATNKAGEDEKQAF | 281 | O15394 | |
| QTREKAKFSDGEKCR | 246 | Q9UMS5 | |
| CSESGDERKNLEEKS | 16 | Q6NUQ1 | |
| EKLEQCGFFDDNIRK | 701 | O43511 | |
| RDSLTNGEYCKKEEE | 691 | P50443 | |
| FDEDNRGLDNRKCKS | 71 | Q96R05 | |
| NRKCPVKFDDTSDDE | 256 | Q5SVQ8 | |
| KKKAGDQEEESCEFS | 821 | Q12772 | |
| NDVQGRFEKCVSAKE | 156 | Q13426 | |
| RFEKCVSAKEALETD | 161 | Q13426 | |
| VQDEGTKEEDKALAC | 361 | Q9H5I5 | |
| EGRNSSDCRDNEIKK | 836 | Q92576 | |
| CGSKFKSNSDREARE | 111 | Q2T9K0 | |
| ITGICNDETVFAKDK | 646 | P47989 | |
| NDETVFAKDKVTCVG | 651 | P47989 | |
| GDAFDCKVEEVIDKF | 781 | Q70Z35 | |
| AAEKSCKHGAEDRTQ | 531 | O14795 | |
| RGSACSNRSIKKEDD | 596 | Q5SNT2 | |
| GDLTSEDIACNFESK | 1496 | Q4KWH8 | |
| SDEKSAFLKSLGCDR | 206 | Q8N4Q0 | |
| TAADEVREKLGSSCK | 51 | Q9BV44 | |
| EDAKGKSEEELAECF | 86 | P02585 | |
| FLTGEKSCKDDEFRK | 236 | Q5TYW1 | |
| AGEKSRECDKSNKVF | 336 | P51814 | |
| ETNGGAEKKSSCFIE | 126 | Q9UJ78 | |
| KALDGDFSEDNRNKC | 1546 | Q9Y4G6 | |
| LNQCGKSFEKSTVEE | 311 | Q9Y2H8 | |
| AGEKIEECEKTFSKD | 346 | Q96JF6 | |
| AGEKLEECEKTFSKD | 731 | Q96JF6 | |
| RGKDKSENQDCLTFL | 201 | Q8TEC5 | |
| NDLSCDLSDSKDAFK | 411 | Q9NRL3 | |
| ERVCIGANDKKEEFD | 776 | Q9C0G0 | |
| DECGKAFRQRSDLSK | 556 | O43309 | |
| SDCEEAFFKKSELIR | 396 | Q86T29 | |
| DSKKESCFELTSQDR | 171 | Q86WV1 | |
| DCKADAEEGIFEIKT | 101 | Q9BYX2 | |
| DGCDRKFANSSDRKK | 526 | Q96T25 | |
| KCFEISDADTKEVFA | 66 | P53350 | |
| ARGSSNASLKEEECK | 196 | Q92539 | |
| NKDSKATSEREACGL | 1411 | Q8NEV4 | |
| CEGFLEKNKDTVFEE | 561 | Q9Y4I1 | |
| KASEQAVFKCEVSDE | 451 | Q14324 | |
| VGAKDQAVFKCEVSD | 556 | Q14896 |